SyAllgen (Syntrion GmbH)
Welcome to the PulseAid listing for the SyAllgen drug offered from Syntrion GmbH. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Syntrion GmbH |
| NON-PROPRIETARY NAME: | PENICILLIUM GLABRUM |
| SUBSTANCE NAME: | PENICILLIUM GLABRUM |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
| START MARKETING DATE: | 2015-02-15 |
| END MARKETING DATE: | 2019-11-30 |
SyAllgen HUMAN OTC DRUG Details:
| Item Description | SyAllgen from Syntrion GmbH |
| LABELER NAME: | Syntrion GmbH |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 250(mg/1) |
| START MARKETING DATE: | 2015-02-15 |
| END MARKETING DATE: | 2019-11-30 |
| PRODUCT ID: | 10424-101_fb193dd0-996d-4a58-ad6f-3354555963a4 |
| PRODUCT NDC: | 10424-101 |
| APPLICATION NUMBER: | |
Other PENICILLIUM GLABRUM Pharmaceutical Manufacturers / Labelers:
